1. Effects of pentoxifylline on the hepatic content of TGF-beta1 and collagen in Schistosomiasis japonica mice with liver fibrosis.
- Author
-
Xiong LJ, Zhu JF, Luo DD, Zen LL, and Cai SQ
- Subjects
- Animals, Anthelmintics pharmacology, Female, Liver metabolism, Liver Cirrhosis metabolism, Liver Cirrhosis parasitology, Liver Cirrhosis pathology, Mice, Praziquantel pharmacology, Random Allocation, Schistosomiasis japonica complications, Schistosomiasis japonica pathology, Transforming Growth Factor beta1, Collagen Type I metabolism, Collagen Type III metabolism, Liver drug effects, Liver pathology, Pentoxifylline pharmacology, Schistosomiasis japonica metabolism, Transforming Growth Factor beta metabolism
- Abstract
Aim: To study the effects of pentoxifylline (PTX) on the content of hepatic TGF-beta1, type I and type III collagen in schistosomiasis japonica mice with liver fibrosis and its mechanism of anti-fibrosis., Methods: Forty mice with schistosomiasis were divided into four groups: one group as control without any treatment, other three were treated with Praziquantel 500 mg/(kg x d)for 2 d, high dose PTX 360 mg/(kg x d) for 8 wk, and low dose PTX 180 mg/(kg x d) for 8 wk respectively. Immunohistochemical technique and multimedia color pathographic analysis system were applied to observe the content change of hepatic TGF-beta1, type I and type III collagen in schistosomiasis japonica mice with liver fibrosis before and after PTX treatment., Results: Effects of PTX on the content change of hepatic TGF-beta1, type I and type III collagen in schistosomiasis japonica mice with liver fibrosis were related to the dosage of PTX, high dose PTX treated group could significantly reduce the content of TGF-beta1 (0.709+/-0.111), type I (0.644+/-0.108) and type III (0.654+/-0.152) collagen compared with those of control group (0.883+/-0.140, 0.771+/-0.156, 0.822+/-0.129) with statistical significance (P<0.05). Low dose PTX could also reduce the hepatic content of TGF-beta1 (0.752+/-0.152), type I (0.733+/-0.117) and type III (0.788+/-0.147) collagen, but without statistical significance (P>0.05). Both high dose and low dose PTX groups have significant differences on the content of TGF-beta1, type I and type III collagen (P<0.05, P<0.05, P<0.01, respectively)., Conclusion: High dose of PTX treatment could reduce the content of hepatic TGF-beta1, type I and type III collagen significantly in schistosomiasis japonica mice with liver fibrosis, and thus plays its role of antifibrosis.
- Published
- 2003
- Full Text
- View/download PDF